Kód HS/CN 30021091 je pre prípravu EUDR mimo rozsahu pôsobnosti.
Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001) Indexovaný motor rozsahu pôsobnosti vracia pre tento kód Out of scope. No Annex I scope match was found for this indexed CN code.
Prečo táto referenčná stránka dáva takúto odpoveď.
- Popis kódu
- Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001)
- Základ v Prílohe I
- Žiadna priama položka v Prílohe I
- Základ zdroja
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Nadradené, podradené a susedné riadky.
Zobrazenie knižnice slúži na referenčnú navigáciu. Ak chcete spustiť ďalší kód ako akciu, použite nástroj na kontrolu.
30pharmaceutical productsout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Čo to znamená pre prípravu.
Tento riadok nie je v aktuálnom výsledku rozsahu pôsobnosti priamym spúšťačom zhromažďovania dokladov.
Regulation (EU) 2023/1115 Annex I — relevant productszískané 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115získané 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)získané 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)získané 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8získané 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingzískané 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and traderszískané 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)získané 2026-08-08